Evolus - Stock Price History | EOLS

Historical daily share price chart and data for Evolus since 2020 adjusted for splits. The latest closing stock price for Evolus as of September 18, 2020 is 3.87.
  • The all-time high Evolus stock closing price was 38.49 on June 06, 2018.
  • The Evolus 52-week high stock price is 18.78, which is 385.3% above the current share price.
  • The Evolus 52-week low stock price is 3.00, which is 22.5% below the current share price.
  • The average Evolus stock price for the last 52 weeks is 8.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Evolus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 17.9324 12.4300 28.9100 11.5800 12.1700 2.27%
2018 16.8620 11.5000 38.4900 6.8500 11.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.131B $0.035B
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $189.199B 35.50
Medtronic (MDT) Ireland $144.638B 27.24
Stryker (SYK) United States $77.357B 30.00
Boston Scientific (BSX) United States $55.052B 31.80
Lonza Group Ag (LZAGY) Switzerland $46.603B 0.00
Baxter (BAX) United States $42.002B 25.69
Terumo (TRUMY) Japan $30.472B 38.95
EssilorLuxottica Societe Anonyme (ESLOY) France $29.029B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.753B 23.86
ResMed (RMD) United States $24.635B 35.72
Smith & Nephew SNATS (SNN) United Kingdom $17.209B 0.00
Sunny Optical Technology (SNPTF) China $17.067B 0.00
Bio-Rad Laboratories (BIO) United States $15.239B 68.92
Insulet (PODD) United States $14.773B 625.06
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $7.942B 42.07
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.424B 11.02
Canopy Growth (CGC) Canada $6.075B 0.00
Hill-Rom Holdings (HRC) United States $5.499B 13.65
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.571B 0.00
Haemonetics (HAE) United States $4.202B 28.00
ICU Medical (ICUI) United States $4.157B 31.71
Neogen (NEOG) United States $4.000B 66.75
Envista Holdings (NVST) United States $3.888B 26.51
Abcam (ABCZY) $3.404B 0.00
TG Therapeutics (TGTX) United States $3.312B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.110B 0.00
National Vision Holdings (EYE) United States $3.084B 479.38
Agios Pharmaceuticals (AGIO) United States $2.658B 0.00
NuVasive (NUVA) United States $2.541B 35.41
DFB Healthcare Acquisitions (AHCO) United States $1.908B 174.08
AtriCure (ATRC) United States $1.797B 0.00
NanoString Technologies (NSTG) United States $1.748B 0.00
MacroGenics (MGNX) United States $1.710B 0.00
Cardiovascular Systems (CSII) United States $1.422B 0.00
Aphria (APHA) Canada $1.349B 0.00
InMode (INMD) Israel $1.158B 29.21
Cerus (CERS) United States $1.052B 0.00
Quanterix (QTRX) United States $0.964B 0.00
Owens & Minor (OMI) United States $0.915B 20.49
OraSure Technologies (OSUR) United States $0.900B 0.00
PetIQ (PETQ) United States $0.883B 25.34
BioLife Solutions (BLFS) United States $0.871B 453.50
Lantheus Holdings (LNTH) United States $0.863B 11.96
Aurora Cannabis (ACB) Canada $0.754B 0.00
Phibro Animal Health (PAHC) United States $0.727B 16.63
Vapotherm (VAPO) United States $0.725B 0.00
Meridian Bioscience (VIVO) United States $0.714B 16.49
Omeros (OMER) United States $0.671B 0.00
LeMaitre Vascular (LMAT) United States $0.667B 40.69
Zynex (ZYXI) United States $0.597B 52.12
Eagle Pharmaceuticals (EGRX) United States $0.542B 76.60
Surmodics (SRDX) United States $0.537B 58.94
VAREX IMAGING (VREX) United States $0.486B 21.07
Cytosorbents (CTSO) United States $0.374B 0.00
HEXO (HEXO) $0.374B 0.00
Viemed Healthcare (VMD) United States $0.368B 13.15
Utah Medical Products (UTMD) United States $0.297B 25.49
Surface Oncology (SURF) United States $0.289B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.280B 0.00
InfuSystems Holdings (INFU) United States $0.277B 52.73
Organigram Holdings (OGI) Canada $0.222B 0.00
Female Health (VERU) United States $0.201B 0.00
Chimerix (CMRX) United States $0.177B 0.00
Wound Management Technologies (SMTI) United States $0.172B 0.00
Bovie Medical (APYX) United States $0.169B 0.00
Fonar (FONR) United States $0.163B 14.48
Exagen (XGN) United States $0.161B 0.00
Liberty Health Sciences (LHSIF) Canada $0.135B 0.00
Capricor Therapeutics (CAPR) United States $0.110B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.098B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Rockwell Medical (RMTI) United States $0.090B 0.00
United-Guardian (UG) United States $0.070B 15.64
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
MTech Acquisition (KERN) United States $0.059B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 10.64
Nephros (NEPH) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
FSD PHARMA INC (HUGE) Canada $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Myomo (MYO) United States $0.018B 0.00
NF Energy Saving (BIMI) China $0.018B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00